Krishna Sriram

InstitutionGold Coast University Hospital
AddressQueensland
Australia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in May 2020 and July 2020 and October 2020
    All Publications
    Bar chart showing 40 publications over 13 distinct years, with a maximum of 8 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ajmera V, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Sriram K, Insel PA, Collier S, Richards L, Loomba R. RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. Contemp Clin Trials. 2021 04; 103:106330. PMID: 33631357.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    2. Sriram K, Loomba R, Insel PA. Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges. Proc Natl Acad Sci U S A. 2020 11 24; 117(47):29274-29282. PMID: 33203679.
      Citations: 8     Fields:    Translation:HumansAnimals
    3. Sriram K, Insel PA. Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets. Physiol Rev. 2021 04 01; 101(2):545-567. PMID: 33124941.
      Citations: 11     Fields:    Translation:Humans
    4. Sriram K, Loomba R, Insel PA. RAAS Inhibitors and Risk of Covid-19. N Engl J Med. 2020 Nov 12; 383(20):1991-1992. PMID: 33108103.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    5. Parker J, Niranjan S, Sriram KB. A case of broken heart syndrome via the telephone: socially distant outpatient clinics in the COVID-19 pandemic. Intern Med J. 2020 11; 50(11):1429-1431. PMID: 32827338.
      Citations: 1     Fields:    Translation:Humans
    6. Sriram K, Insel PA. Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19? Br J Pharmacol. 2020 11; 177(21):4971-4974. PMID: 32639031.
      Citations: 9     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Sriram K, Insel PA. Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients. Am J Physiol Lung Cell Mol Physiol. 2020 07 01; 319(1):L37-L38. PMID: 33496632.
      Citations:    Fields:    Translation:Humans
    8. Sriram K, Insel PA. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance. Br J Pharmacol. 2020 11; 177(21):4825-4844. PMID: 32333398.
      Citations: 66     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    9. Sriram K, Insel PA. Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence. Clin Pharmacol Ther. 2020 08; 108(2):236-241. PMID: 32320478.
      Citations: 63     Fields:    Translation:HumansAnimalsPHPublic Health